|
|
|
|
|
WELCOME
|
|
7:00 AM - 8:00 AM |
Registration and Breakfast
|
|
8:00 AM - 8:10 AM |
Opening Remarks
Presented by: Dr. Paul Wheatley-Price
|
|
|
Rare Mutations Section
Dr. Unice Chang
|
|
8:10 AM - 8:15 AM |
HER2 Case Presentation
Presented by: Dr. Unice Chang
|
|
8:15 AM - 8:40 AM |
What About HER? HER2-Targeted Treatments in Lung Cancer
Presented by: Dr. Maisam Makaram
|
|
8:40 AM - 8:45 AM |
Atypical EGFR Mutation Case Presentation
Presented by: Dr. Alec Watson
|
|
8:45 AM - 9:10 AM |
Not Your Typical EGFR: Advancements in the Management of Atypical EGFR Mutations in Lung Cancer
Presented by: Dr. Dan Breadner
|
|
9:10 AM - 9:40 AM |
KRASh Course on KRAS Non-G12C Mutated Lung Cancer
Presented by: Dr. Adrian Sacher
|
|
9:40 AM - 10:00 AM |
Managing the Mutants: Panel Discussion and Questions for Atypical EGFR, HER2, and KRAS non-G12C
Dr. Maisam Makaram, Dr. Dan Breadner, and Dr. Adrian Sacher
|
|
10:00 AM - 10:30 AM |
Morning Networking Break
|
|
|
Rare Fusions Section
Moderated by: Dr. Janessa Laskin
|
|
10:30 AM - 10:35 AM |
ROS1 Case Presentation
Presented by: Dr. Alice Mogenet
|
|
10:35 AM - 11:00 AM |
A ROSy Outlook? Advancements in the Treatment of ROS1 Mutated Lung Cancers
Presented by: Dr. Ross Camidge
|
|
11:00 AM - 11:10 AM |
NRG1 Discovery and Case Presentation
Presented by: Dr. Janessa Laskin
|
|
11:10 AM - 11:30 AM |
Feeling NRGetic: Mechanisms and Advancements in the Treatment of NRG1 Mutated Lung Cancers
Presented by: Dr. Parneet Cheema
|
|
11:30 AM - 11:35 AM |
NTRK Case Presentation
Presented by: Dr. Katherina Baranova
|
|
11:35 AM - 12:00 PM |
NTRK: The Next Generation
Presented by Dr. Cheryl Ho
|
|
12:00 PM - 12:20 PM |
The Future of Fusions: Panel Discussion and Questions for NRG1 and NTRK
Dr. Janessa Laskin, Dr. Ross Camidge, Dr. Parneet Cheema, and Dr. Cheryl Ho
|
|
12:20 PM - 1:20 PM |
Networking Lunch
|
|
|
Looking to the Future
Moderated by: Dr. Scott Laurie
|
|
1:20 PM - 1:35 PM |
SMARC for Dummies: Pathobiology of SMARCA4
Presented by: Dr. Basile Tessier-Cloutier
|
|
1:35 PM - 1:50 PM |
What the SMARC? Natural History and Clinical Impact
Presented by Dr. Sara Moore
|
|
1:50 PM - 1:55 PM |
MTAP Case Presentation
Presented by: Dr. Florence Wu
|
|
1:55 PM - 2:05 PM |
An Intricate TAP Dance: The Pathobiology of MTAP Deleted Lung Cancers
Presented by: Dr. Julia Naso
|
|
2:05 PM - 2:30 PM |
Treatments on TAP: Management of MTAP Deleted Lung Cancers
Presented by: Dr. Pasi Janne
|
|
2:30 PM - 2:45 PM |
Future targets: Panel Discussion and Questions for SMARCA4 and MTAP
Dr. Basile Tessier-Cloutier, Dr. Sara Moore, Dr. Julia Naso, and Dr. Pasi Janne
|
|
2:45 PM - 3:10 PM |
Afternoon Networking Break
|
|
|
Testing and Reporting
Moderated by: Natasha Leighl
|
|
3:10 PM - 3:15 PM |
Diving in: Let’s Talk Liquid Biopsy
Presented by: Dr. Natasha Leighl
|
|
3:15 PM - 3:35 PM |
Making a Splash: The Role of Liquid Biopsy in Detecting Actionable Mutations
Presented by: Dr. David Tsui
|
|
3:35 PM - 3:55 PM |
Uncharted Waters: New Directions in Liquid Biopsy
Presented by: Dr. Charu Aggarwal
|
|
3:55 PM - 4:15 PM |
Oceans of Data: What should be reported on NGS reports?
Presented by Dr. Brandon Sheffield
|
|
4:15 PM - 4:30 PM |
It’s in our DNA: Panel Discussion and Questions for Liquid Biopsy and NGS Testing
Dr. Natasha Leighl, Dr. David Tsui, Dr. Charu Aggarwal, and Dr. Brandon Sheffield
|
|
4:30 PM - 4:45 PM |
Closing Remarks
Presented by: Dr. Paul Wheatley-Price, Dr. Scott Laurie, and Dr. Unice Chang
|
